middle.news
Telix Boosts US Reach with $230M Acquisition of RLS Radiopharmacies
8:27am on Tuesday 28th of January, 2025 AEDT
•
Biopharmaceutical
Read Story
Telix Boosts US Reach with $230M Acquisition of RLS Radiopharmacies
8:27am on Tuesday 28th of January, 2025 AEDT
Key Points
Acquisition of RLS (USA) Inc. completed for US$230 million upfront
RLS operates America’s only Joint Commission-accredited radiopharmacy network
Network includes over 30 radiopharmacies and 100,000 sq ft licensed expansion space
Integration strengthens Telix’s US commercial infrastructure and manufacturing capabilities
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Telix Pharmaceuticals (ASX:TLX)
OPEN ARTICLE